StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) income statement

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$17.83−0.35 (-1.93%)

Close on Nov 18, 2026Market cap $1.10BP/E –Yield –

Vor Biopharma Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
2057.7%

Financial strength

Current ratio
13.50
Debt to equity
–
Debt to assets
–
Cash to current liabilities
217.3%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?